MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-12-2024
Cutera DSO Ratio 2011-2026 | CUTR
Annual DSO Ratio Cutera
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 327 | 209 | 42.1 | 53.8 | 43.3 | 44 | 50.1 | 51.2 | 44.9 | 52 | 47.4 | 41.8 | 31.4 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 327 | 31.4 | 79.8 |
Quarterly DSO Ratio Cutera
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 95 | 103 | - | 101 | 77.7 | 81.1 | - | 49.4 | 46.4 | 50.8 | - | 45 | 39 | 42.4 | 40.1 | 51.2 | 76 | 61.6 | 38 | 42.6 | 41.2 | 52.2 | 39.4 | 44.2 | 42.1 | 54 | 39.8 | 49.7 | 52.1 | 58.1 | 39.9 | 49.9 | 55 | 57.4 | 35.4 | 46.1 | 47.2 | 54.6 | 39.9 | 54.3 | 57.3 | 58.7 | 39.7 | 52.5 | 45.1 | 52.9 | 35.8 | 41.5 | 41.2 | 40.7 | 25.6 | 31.1 | 31.8 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 103 | 25.6 | 50.9 |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AdaptHealth Corp.
AHCO
|
43.8 | $ 13.17 | 0.46 % | $ 1.78 B |  USA |
 |
BIOLASE
BIOL
|
42 | - | -13.19 % | $ 166 K | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | USA |
 |
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M |  China |
 |
Eargo
EAR
|
70.8 | - | - | $ 10.2 M | USA |
 |
Delcath Systems
DCTH
|
48.5 | $ 10.8 | 4.05 % | $ 387 M | USA |
 |
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | USA |
 |
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
137 | $ 25.6 | -0.43 % | $ 216 M | USA |
 |
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | USA |
 |
EDAP TMS S.A.
EDAP
|
91.8 | $ 3.47 | 4.52 % | $ 130 M |  France |
 |
Aziyo Biologics
AZYO
|
59.5 | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
Helius Medical Technologies
HSDT
|
53.3 | $ 2.12 | 3.92 % | $ 1.29 M | USA |
 |
Inspire Medical Systems
INSP
|
42.6 | $ 56.7 | 1.0 % | $ 1.67 B | USA |
 |
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | USA |
 |
LivaNova PLC
LIVN
|
53.8 | $ 61.0 | 1.5 % | $ 3.33 B |  Britain |
 |
ClearPoint Neuro
CLPT
|
55.6 | $ 11.37 | 1.7 % | $ 322 M | USA |
 |
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
73.2 | $ 0.61 | 0.36 % | $ 38 M | USA |
 |
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | USA |
 |
Invacare Corporation
IVC
|
206 | - | - | $ 24.7 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | USA |
 |
IRIDEX Corporation
IRIX
|
47.5 | $ 1.03 | - | $ 17.4 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | USA |
 |
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
120 | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
74.3 | $ 15.65 | 3.92 % | $ 367 M | USA |
 |
Butterfly Network
BFLY
|
76.1 | $ 5.4 | 12.97 % | $ 1.14 B | USA |
 |
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | USA |
 |
GBS
GBS
|
61.2 | - | -0.57 % | $ 7.12 M | USA |
 |
Sintx Technologies
SINT
|
67 | $ 2.41 | 14.22 % | $ 6.68 M | USA |
 |
Globus Medical
GMED
|
76.8 | $ 91.34 | 1.29 % | $ 12.4 B | USA |
 |
TransMedics Group
TMDX
|
54.9 | $ 100.01 | -0.77 % | $ 3.4 B | USA |
 |
NanoVibronix
NAOV
|
27.7 | - | - | $ 1.08 M | USA |
 |
CONMED Corporation
CNMD
|
64.5 | $ 36.8 | 0.38 % | $ 1.14 B | USA |
 |
Integer Holdings Corporation
ITGR
|
58.2 | $ 84.03 | -5.06 % | $ 2.92 B | USA |
 |
Stryker Corporation
SYK
|
204 | $ 294.73 | -6.47 % | $ 113 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
38.2 | $ 83.98 | 0.57 % | $ 49.1 B | USA |
 |
Tandem Diabetes Care
TNDM
|
176 | $ 19.41 | -0.61 % | $ 1.32 B | USA |
 |
LENSAR
LNSR
|
38.9 | $ 5.61 | 7.27 % | $ 67.1 M | USA |
 |
Pulmonx Corporation
LUNG
|
50.8 | $ 1.35 | 5.47 % | $ 54.9 M | USA |
 |
MiMedx Group
MDXG
|
57.3 | $ 3.68 | 9.52 % | $ 544 M | USA |
 |
Myomo
MYO
|
35.3 | $ 0.9 | 4.16 % | $ 37.7 M | USA |